BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

218 related articles for article (PubMed ID: 23299095)

  • 1. Attenuation of cocaine and heroin seeking by μ-opioid receptor antagonism.
    Giuliano C; Robbins TW; Wille DR; Bullmore ET; Everitt BJ
    Psychopharmacology (Berl); 2013 May; 227(1):137-47. PubMed ID: 23299095
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inhibition of opioid transmission at the μ-opioid receptor prevents both food seeking and binge-like eating.
    Giuliano C; Robbins TW; Nathan PJ; Bullmore ET; Everitt BJ
    Neuropsychopharmacology; 2012 Nov; 37(12):2643-52. PubMed ID: 22805601
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Novel μ-Opioid Receptor Antagonist GSK1521498 Decreases Both Alcohol Seeking and Drinking: Evidence from a New Preclinical Model of Alcohol Seeking.
    Giuliano C; Goodlett CR; Economidou D; García-Pardo MP; Belin D; Robbins TW; Bullmore ET; Everitt BJ
    Neuropsychopharmacology; 2015 Dec; 40(13):2981-92. PubMed ID: 26044906
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The novel mu-opioid antagonist, GSK1521498, reduces ethanol consumption in C57BL/6J mice.
    Ripley TL; Sanchez-Roige S; Bullmore ET; Mugnaini M; Maltby K; Miller SR; Wille DR; Nathan P; Stephens DN
    Psychopharmacology (Berl); 2015 Sep; 232(18):3431-41. PubMed ID: 26141191
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The opioid receptor pharmacology of GSK1521498 compared to other ligands with differential effects on compulsive reward-related behaviours.
    Kelly E; Mundell SJ; Sava A; Roth AL; Felici A; Maltby K; Nathan PJ; Bullmore ET; Henderson G
    Psychopharmacology (Berl); 2015 Jan; 232(1):305-14. PubMed ID: 24973897
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cocaine and heroin ('speedball') self-administration: the involvement of nucleus accumbens dopamine and mu-opiate, but not delta-opiate receptors.
    Cornish JL; Lontos JM; Clemens KJ; McGregor IS
    Psychopharmacology (Berl); 2005 Jun; 180(1):21-32. PubMed ID: 15682301
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Heroin self-administration under a second-order schedule of reinforcement: acquisition and maintenance of heroin-seeking behaviour in rats.
    Alderson HL; Robbins TW; Everitt BJ
    Psychopharmacology (Berl); 2000 Dec; 153(1):120-33. PubMed ID: 11255922
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Self-administration of cocaine-heroin combinations by rhesus monkeys: antagonism by naltrexone.
    Rowlett JK; Wilcox KM; Woolverton WL
    J Pharmacol Exp Ther; 1998 Jul; 286(1):61-9. PubMed ID: 9655842
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A role for kappa-, but not mu-opioid, receptor activation in acute food deprivation-induced reinstatement of heroin seeking in rats.
    Sedki F; Eigenmann K; Gelinas J; Schouela N; Courchesne S; Shalev U
    Addict Biol; 2015 May; 20(3):423-32. PubMed ID: 24725195
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Opioid Antagonists and the A118G Polymorphism in the μ-Opioid Receptor Gene: Effects of GSK1521498 and Naltrexone in Healthy Drinkers Stratified by OPRM1 Genotype.
    Ziauddeen H; Nestor LJ; Subramaniam N; Dodds C; Nathan PJ; Miller SR; Sarai BK; Maltby K; Fernando D; Warren L; Hosking LK; Waterworth D; Korzeniowska A; Win B; Richards DB; Vasist Johnson L; Fletcher PC; Bullmore ET
    Neuropsychopharmacology; 2016 Oct; 41(11):2647-57. PubMed ID: 27109624
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Selective norepinephrine reuptake inhibition by atomoxetine prevents cue-induced heroin and cocaine seeking.
    Economidou D; Dalley JW; Everitt BJ
    Biol Psychiatry; 2011 Feb; 69(3):266-74. PubMed ID: 21109233
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Decrease of cocaine, but not heroin, self-administration and relapse by the tyrosine kinase inhibitor masitinib in male Sprague Dawley rats.
    Belin-Rauscent A; Lacoste J; Hermine O; Moussy A; Everitt BJ; Belin D
    Psychopharmacology (Berl); 2018 May; 235(5):1545-1556. PubMed ID: 29520592
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Intravenous self-administration of etonitazene alone and combined with cocaine in rhesus monkeys: comparison with heroin and antagonism by naltrexone and naloxonazine.
    Achat-Mendes C; Valdez GR; Platt DM; Rowlett JK; Spealman RD
    Psychopharmacology (Berl); 2009 Jun; 204(3):489-98. PubMed ID: 19225763
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Self-Administration of cocaine-opioid combinations by rhesus monkeys: evaluation of the role of mu receptor efficacy using labor supply analysis.
    Rowlett JK; Rodefer JS; Spealman RD
    J Pharmacol Exp Ther; 2005 Mar; 312(3):1289-97. PubMed ID: 15550572
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of the mu-opioid receptor antagonist GSK1521498 on hedonic and consummatory eating behaviour: a proof of mechanism study in binge-eating obese subjects.
    Ziauddeen H; Chamberlain SR; Nathan PJ; Koch A; Maltby K; Bush M; Tao WX; Napolitano A; Skeggs AL; Brooke AC; Cheke L; Clayton NS; Sadaf Farooqi I; O'Rahilly S; Waterworth D; Song K; Hosking L; Richards DB; Fletcher PC; Bullmore ET
    Mol Psychiatry; 2013 Dec; 18(12):1287-93. PubMed ID: 23147384
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evidence for a Long-Lasting Compulsive Alcohol Seeking Phenotype in Rats.
    Giuliano C; Peña-Oliver Y; Goodlett CR; Cardinal RN; Robbins TW; Bullmore ET; Belin D; Everitt BJ
    Neuropsychopharmacology; 2018 Mar; 43(4):728-738. PubMed ID: 28553834
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Association of time-dependent changes in mu opioid receptor mRNA, but not BDNF, TrkB, or MeCP2 mRNA and protein expression in the rat nucleus accumbens with incubation of heroin craving.
    Theberge FR; Pickens CL; Goldart E; Fanous S; Hope BT; Liu QR; Shaham Y
    Psychopharmacology (Berl); 2012 Dec; 224(4):559-71. PubMed ID: 22790874
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Regulation of ingestive behaviors in the rat by GSK1521498, a novel micro-opioid receptor-selective inverse agonist.
    Ignar DM; Goetz AS; Noble KN; Carballo LH; Stroup AE; Fisher JC; Boucheron JA; Brainard TA; Larkin AL; Epperly AH; Shearer TW; Sorensen SD; Speake JD; Hommel JD
    J Pharmacol Exp Ther; 2011 Oct; 339(1):24-34. PubMed ID: 21712426
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Differential vulnerability to relapse into heroin versus cocaine-seeking as a function of setting.
    Montanari C; Stendardo E; De Luca MT; Meringolo M; Contu L; Badiani A
    Psychopharmacology (Berl); 2015 Jul; 232(13):2415-24. PubMed ID: 25662790
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Specific and nonspecific effects of naltrexone on goal-directed and habitual models of alcohol seeking and drinking.
    Hay RA; Jennings JH; Zitzman DL; Hodge CW; Robinson DL
    Alcohol Clin Exp Res; 2013 Jul; 37(7):1100-10. PubMed ID: 23398292
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.